Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Daiichi reports novel cytokine production inhibitors in patent literature

Aug. 4, 1999

Novel selectin inhibitors revealed in the patent literature by Sumitomo

Aug. 2, 1999

Amgen discloses new class of cytokine production inhibitors

July 30, 1999

Aryl ureas for cytokine- and MMP-mediated conditions disclosed by Bayer

July 30, 1999

Cytokine production inhibitors from SB particularly useful for inflammation, osteoporosis

July 27, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

Fungal metabolites useful as IL-1/TNF production inhibitors

July 23, 1999

P2X7 receptor antagonists for inflammatory, immune and cardiovascular disorders

July 23, 1999

Licensing opportunity from NIH: broad-spectrum chemokine antagonist

July 22, 1999

Amgen reveals latest in inhibitors of matrix metalloproteinases

July 21, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...